Listened
In progress
A new potential Alzheimer’s therapy uses 40-hertz frequencies of light and sound to stimulate the brain. Research applying this treatment to mice showed a substantial decrease in amyloid plaques, a key biomarker for the disease, and an improvement in cognitive function. Clinical trials testing the efficacy of this method in humans are underway.
But how exactly does this treatment work? Could it be a game changer in Alzheimer’s patients? And what potential does it have for other degenerative diseases, like multiple sclerosis?
A new potential Alzheimer’s therapy uses 40-hertz frequencies of light and sound to stimulate the brain. Research applying this treatment to mice showed a substantial decrease in amyloid plaques, a key biomarker for the disease, and an improvement in cognitive function. Clinical trials testing the efficacy of this method in humans are underway.
But how exactly does this treatment work? Could it be a game changer in Alzheimer’s patients? And what potential does it have for other degenerative diseases, like multiple sclerosis?
Ira talks with Dr. Li-Huei Tsai, professor of neuroscience and director of Picower Institute for Learning and Memory at the Massachusetts Institute of Technology, about her work developing this therapy.
Transcript for this segment will be available after the show airs on sciencefriday.com.
Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
QUICK LINKS
This is an episodic podcast, so you can listen to it in any order, but episode one is a great place to start.
Listen to episode one hereA new potential Alzheimer’s therapy uses 40-hertz frequencies of light and sound to stimulate the brain. Research applying this treatment to mice showed a substantial decrease in amyloid plaques, a key biomarker for the disease, and an improvement in cognitive function. Clinical trials testing the efficacy of this method in humans are underway.
But how exactly does this treatment work? Could it be a game changer in Alzheimer’s patients? And what potential does it have for other degenerative diseases, like multiple sclerosis?
Ira talks with Dr. Li-Huei Tsai, professor of neuroscience and director of Picower Institute for Learning and Memory at the Massachusetts Institute of Technology, about her work developing this therapy.
Transcript for this segment will be available after the show airs on sciencefriday.com.
Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Sound Carrot is your source for Family Podcast Discovery. Verified awesome, 0% boring.
Distraction free website, no flashing banners or adverts to steal your attention.
(Some shows do contain their own ads however).
At first I made this site for my kids, but like any dad I got a little over excited. I hope you find it as useful as they do.
Whether you want to listen to them together in the car, or alone in your room - the content is all safe for younger ears.